JR
Jason Robins
CFO & Principal Accounting OfficerMr. Jason Robins, also known as Jay, is CFO of Ocular Therapeutix, Inc. from June 10, 2026 and serves as its Principal Accounting Officer since January 20, 2026 and was its Interim CFO from January 20, 2026 to June 10, 2026. Mr. Robins was Senior Vice President of Finance of Ocular Therapeutix, Inc. since January 2025. From October 2020 to December 2024, Mr. Robins served as Vice President, Finance, of Fusion Pharmaceuticals Inc., a biopharmaceutical company acquired by AstraZeneca in June 2024. Mr. Robins received a Bachelor of Science from Babson College, a Master of Science from the Harvard-MIT Division of Health Sciences and Technology and a Master of Business Administration from the MIT Sloan School of Management.
Positions
- Company NameOcular Therapeutix, Inc.Stock CodeOCULPositionCFO & Principal Accounting OfficerColleagues
- PUPravin U. DugelExecutive Chairman, President & CEO
- DNDonald NotmanChief Operating Officer (Leave of Absence)
- SMSteve MeyersChief Commercial Officer
- NKNadia K. WaheedChief Medical Officer
- CMCharles M. WardenLead Independent Director
- RLRichard L. LindstromIndependent Director
- LJLeslie J. WilliamsIndependent Director
- MRMerilee RainesIndependent Director
